The task is to provide a new dichroic compound, a liquid crystal composition containing the compound, and a liquid crystal element. The solution is a dichroic compound represented by general formula (1), a liquid crystal composition containing the compound, and a liquid crystal element. (In the formula, R1 to R4 independently represent a hydrogen atom, a straight chain, branched or cyclic alkyl group, a straight chain, branched or cyclic alkoxy group, or a substituted or unsubstituted aryl group (however, R1 to R4 do not represent a hydrogen atom at the same time)). No selection figure is provided.
Process for Productions of Formamides and Acrylamides
申请人:SHENZHEN UV-CHEM TECH INC
公开号:US20200048186A1
公开(公告)日:2020-02-13
This invention relates to performance chemicals field, it discloses a novel and green process for simultaneous productions of formamides as well as mono- and multi-functional acrylamides under very mild conditions and with high efficiency. These substances are widely useful as industrial solvents or raw materials, in particular acrylamides are important olefinically-unsaturated polymerizable monomers in photo-curing materials.
ROOT CANAL TREATMENT MATERIAL AND ROOT CANAL TREATMENT KIT
申请人:FUJIFILM Corporation
公开号:US20180296445A1
公开(公告)日:2018-10-18
The present invention provides a root canal treatment material having excellent curability in a moist environment and a root canal treatment kit containing the root canal treatment material. The root canal treatment material of the present invention includes: at least one compound (A) selected from the group consisting of a compound represented by Formula (1), a compound represented by Formula (2), and a compound represented by Formula (3); an acidic group-containing monomer (B); and a polymerization initiator (C).
Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
申请人:Pregel J. Marko
公开号:US20050176761A1
公开(公告)日:2005-08-11
Tetrhydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.
A dental composition may have good handling properties and low polymerization shrinkage stress, and be capable of producing a cured product having desirable mechanical strength and excellent transparency. A dental composition may include a polymerizable monomer (A), a filler (B), and a polymerization initiator (C), wherein the polymerizable monomer (A) includes a polyfunctional (meth)acrylic monomer (a-1) having an aromatic ring but no hydroxyl group, and a polyfunctional (meth)acrylic monomer (a-2) having an alicyclic skeleton, and the polyfunctional (meth)acrylic monomer (a-1) and the polyfunctional (meth)acrylic monomer (a-2) have a mass ratio (a-1)/(a-2) of 30/70 to 95/5.
NOVEL COMPOUND, COMPOSITION COMPRISING THE COMPOUND AND CURED PRODUCT
申请人:NARUSE Hiroshi
公开号:US20120296061A1
公开(公告)日:2012-11-22
The present invention provides a novel compound and a composition including the compound that exhibit small polymerization shrinkage particularly during curing and are producible at low cost on the industrial scale. The compound of the present invention is represented by Formula (
1
):